RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
EKF Diagnostics Holdings Stock

EKF Diagnostics Holdings Revenue 2024

EKF Diagnostics Holdings Revenue

55.21 M GBP

Ticker

EKF.L

ISIN

GB0031509804

WKN

622434

In 2024, EKF Diagnostics Holdings's sales reached 55.21 M GBP, a 4.95% difference from the 52.61 M GBP sales recorded in the previous year.

The EKF Diagnostics Holdings Revenue history

YEARREVENUE (undefined GBP)GROSS MARGIN (%)
2026e64.0438,16
2025e59.1841,29
2024e55.2144,26
202352.6146,45
202266.6446,24
202181.8448,10
202065.2657,34
201944.9252,82
201842.5453,35
201741.5854,98
201638.5947,48
201530.0548,82
201437.1151,87
201331.851,42
201226.0654,91
201121.6647,92
20106.4857,25
20090.269398,46
20080.475199,15
20071.8645,70
20063.0850,97
20053.2660,74
20042.2474,55

EKF Diagnostics Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into EKF Diagnostics Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by EKF Diagnostics Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects EKF Diagnostics Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of EKF Diagnostics Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into EKF Diagnostics Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing EKF Diagnostics Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on EKF Diagnostics Holdings’s growth potential.

EKF Diagnostics Holdings Revenue, EBIT and net profit per share

DateEKF Diagnostics Holdings RevenueEKF Diagnostics Holdings EBITEKF Diagnostics Holdings Net Income
2026e64.04 M GBP13.6 M GBP8.62 M GBP
2025e59.18 M GBP9.82 M GBP6.78 M GBP
2024e55.21 M GBP7.8 M GBP5.44 M GBP
202352.61 M GBP4.91 M GBP2.35 M GBP
202266.64 M GBP8.55 M GBP-10.1 M GBP
202181.84 M GBP22.13 M GBP15.85 M GBP
202065.26 M GBP15.61 M GBP11.11 M GBP
201944.92 M GBP5.45 M GBP3.68 M GBP
201842.54 M GBP5.75 M GBP10.11 M GBP
201741.58 M GBP3.17 M GBP2.72 M GBP
201638.59 M GBP205,000 GBP-18,000 GBP
201530.05 M GBP-13.75 M GBP-37.12 M GBP
201437.11 M GBP1.33 M GBP-5.69 M GBP
201331.8 M GBP560,000 GBP-1.13 M GBP
201226.06 M GBP210,000 GBP2.33 M GBP
201121.66 M GBP-2.04 M GBP-2.88 M GBP
20106.48 M GBP-1.93 M GBP-3.44 M GBP
2009260,000 GBP-470,000 GBP-200,000 GBP
2008470,000 GBP-540,000 GBP-1.31 M GBP
20071.86 M GBP-580,000 GBP470,000 GBP
20063.08 M GBP470,000 GBP600,000 GBP
20053.26 M GBP570,000 GBP840,000 GBP
20042.24 M GBP-290,000 GBP-590,000 GBP

EKF Diagnostics Holdings stock margins

The EKF Diagnostics Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of EKF Diagnostics Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for EKF Diagnostics Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the EKF Diagnostics Holdings's sales revenue. A higher gross margin percentage indicates that the EKF Diagnostics Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the EKF Diagnostics Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the EKF Diagnostics Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the EKF Diagnostics Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the EKF Diagnostics Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the EKF Diagnostics Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

EKF Diagnostics Holdings Margin History

EKF Diagnostics Holdings Gross marginEKF Diagnostics Holdings Profit marginEKF Diagnostics Holdings EBIT marginEKF Diagnostics Holdings Profit margin
2026e46.45 %21.23 %13.46 %
2025e46.45 %16.6 %11.45 %
2024e46.45 %14.13 %9.86 %
202346.45 %9.34 %4.47 %
202246.24 %12.84 %-15.16 %
202148.1 %27.04 %19.37 %
202057.34 %23.92 %17.03 %
201952.82 %12.12 %8.19 %
201853.35 %13.5 %23.76 %
201754.98 %7.62 %6.53 %
201647.48 %0.53 %-0.05 %
201548.82 %-45.76 %-123.56 %
201451.87 %3.58 %-15.33 %
201351.42 %1.76 %-3.55 %
201254.91 %0.81 %8.94 %
201147.92 %-9.42 %-13.3 %
201057.25 %-29.78 %-53.09 %
200946.45 %-180.77 %-76.92 %
200846.45 %-114.89 %-278.72 %
200745.7 %-31.18 %25.27 %
200650.97 %15.26 %19.48 %
200560.74 %17.48 %25.77 %
200474.55 %-12.95 %-26.34 %

EKF Diagnostics Holdings Aktienanalyse

What does EKF Diagnostics Holdings do?

EKF Diagnostics Holdings PLC is a service business that offers a wide portfolio of diagnostics, medical devices, and point-of-care systems. It is an international company that sells its products in more than 100 countries worldwide. The company has offices in North America, Europe, and Asia-Pacific. EKF Diagnostics Holdings PLC was formed in 2010 through the merger of three diagnostic companies. The history of EKF Diagnostics Holdings PLC began in 1990 with the founding of Hemocontrol. This company developed innovative devices for monitoring blood coagulation in patients with red blood cell abnormalities. In 1995, Dade Behring Diagnostics (DBD) was established as a subsidiary of Hemocontrol, specializing in the manufacture and marketing of diagnostic products. DBD quickly became a major player in the global diagnostics market and was acquired by Siemens in 2006. In 2001, Pointe Scientific was founded, a company focused on the development and production of high-quality diagnostic tests and instruments. The current business model of EKF Diagnostics Holdings PLC is based on four key areas: Diabetes Care, Point-of-Care, Central Lab, and Life Sciences. All four areas aim to develop and offer innovative solutions for better patient care. The Diabetes Care segment offers diagnostic products for monitoring diabetes. It includes HemoScan, a device for measuring hemoglobin A1C, a test that measures blood sugar levels over several months, enabling the diagnosis and monitoring of diabetes. The Point-of-Care segment offers tests and devices for performing diagnoses and treatments directly at the point of care. This includes devices for measuring blood sugar and cholesterol, as well as devices for determining hemoglobin or troponin. The Central Lab segment offers a wide range of diagnostic tests and instruments for determining blood chemistry, hematology, and immunology. This includes autoanalyzers, hemoglobin counters, and blood glucose meters. The Life Sciences segment offers a wide range of diagnostic tests, instruments, and reagents. This includes tests for cancer diagnosis and monitoring thyroid function. The company offers a variety of products to ensure optimal patient care. This includes diagnostic tests for determining infectious diseases or monitoring chronic conditions. EKF Diagnostics Holdings PLC is a company that is constantly evolving and strives to offer innovative products and solutions. The company places great emphasis on research and development to stay at the forefront of the changing market. The company has an experienced team of technicians and scientists dedicated to the development, production, and marketing of diagnostic products. EKF Diagnostics Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding EKF Diagnostics Holdings's Sales Figures

The sales figures of EKF Diagnostics Holdings originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing EKF Diagnostics Holdings’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize EKF Diagnostics Holdings's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in EKF Diagnostics Holdings’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about EKF Diagnostics Holdings stock

How much revenue did EKF Diagnostics Holdings generate this year?

EKF Diagnostics Holdings has achieved a revenue of 55.21 M GBP this year.

How much was the turnover of the company EKF Diagnostics Holdings compared to the previous year?

The revenue of EKF Diagnostics Holdings has increased by 4.95% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of EKF Diagnostics Holdings?

The revenue of EKF Diagnostics Holdings is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of EKF Diagnostics Holdings measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of EKF Diagnostics Holdings so important for investors?

The revenue of EKF Diagnostics Holdings is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does EKF Diagnostics Holdings pay?

Over the past 12 months, EKF Diagnostics Holdings paid a dividend of 0.01 GBP . This corresponds to a dividend yield of about 4.44 %. For the coming 12 months, EKF Diagnostics Holdings is expected to pay a dividend of 0.01 GBP.

What is the dividend yield of EKF Diagnostics Holdings?

The current dividend yield of EKF Diagnostics Holdings is 4.44 %.

When does EKF Diagnostics Holdings pay dividends?

EKF Diagnostics Holdings pays a quarterly dividend. This is distributed in the months of December, December, December, December.

How secure is the dividend of EKF Diagnostics Holdings?

EKF Diagnostics Holdings paid dividends every year for the past 7 years.

What is the dividend of EKF Diagnostics Holdings?

For the upcoming 12 months, dividends amounting to 0.01 GBP are expected. This corresponds to a dividend yield of 4.05 %.

In which sector is EKF Diagnostics Holdings located?

EKF Diagnostics Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von EKF Diagnostics Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of EKF Diagnostics Holdings from 12/1/2023 amounting to 0.012 GBP, you needed to have the stock in your portfolio before the ex-date on 11/2/2023.

When did EKF Diagnostics Holdings pay the last dividend?

The last dividend was paid out on 12/1/2023.

What was the dividend of EKF Diagnostics Holdings in the year 2023?

In the year 2023, EKF Diagnostics Holdings distributed 0.012 GBP as dividends.

In which currency does EKF Diagnostics Holdings pay out the dividend?

The dividends of EKF Diagnostics Holdings are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von EKF Diagnostics Holdings

Our stock analysis for EKF Diagnostics Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of EKF Diagnostics Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.